Series A - Impact Biomedicines

Series A - Impact Biomedicines

Investment Firm

Overview

Impact Biomedicines is pioneering the development of life-changing treatments for patients.

Announced Date

Oct 13, 2017

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Medicxi

Medicxi

Medicxi is a early_stage_venture and seed firm.

Participant Investors

1

Investor Name
Participant InvestorMedicxi

Round Details and Background

Impact Biomedicines raised $22000000 on 2017-10-13 in Series A

Impact Biomedicines is pioneering the development of life-changing treatments for patients.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 26, 2017
Debt Financing - Impact Biomedicines
1-90.0M
Oct 13, 2017
Series A - Impact Biomedicines
1-22.0M

Recent Activity

There is no recent news or activity for this profile.